Cargando…

Methylphenidate dose optimization for ADHD treatment: review of safety, efficacy, and clinical necessity

Attention-deficit/hyperactivity disorder (ADHD) is a chronic psychiatric disorder characterized by hyperactivity and/or inattention and is often associated with a substantial impact on psychosocial functioning. Methylphenidate (MPH), a central nervous system stimulant, is commonly used for pharmacol...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huss, Michael, Duhan, Praveen, Gandhi, Preetam, Chen, Chien-Wei, Spannhuth, Carsten, Kumar, Vinod
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5505611/ https://www.ncbi.nlm.nih.gov/pubmed/28740389 http://dx.doi.org/10.2147/NDT.S130444

Ejemplares similares

Open-Label Dose Optimization of Methylphenidate Modified Release Long Acting (MPH-LA): A Post Hoc Analysis of Real-Life Titration from a 40-Week Randomized Trial
por: Huss, Michael, et al.
Publicado: (2014)

ADHD, Methylphenidate, and Childhood Epilepsy
por: Sharma, Rahul, et al.
Publicado: (2016)

Methylphenidate for Treating ADHD: A Naturalistic Clinical Study of Methylphenidate Blood Concentrations in Children and Adults With Optimized Dosage
por: Chermá, Maria D., et al.
Publicado: (2016)

Predicting Methylphenidate Response in ADHD Using Machine Learning Approaches
por: Kim, Jae-Won, et al.
Publicado: (2015)

Optimization of Methylphenidate Extended-Release Chewable Tablet Dose in Children with ADHD: Open-Label Dose Optimization in a Laboratory Classroom Study
por: Wigal, Sharon B., et al.
Publicado: (2018)

The Risk of Methylphenidate Pharmacotherapy for Adults with ADHD
por: Bieś, Rafał, et al.
Publicado: (2023)

Titrating Optimal Dose of Osmotic-Controlled Release Oral Delivery (OROS)-Methylphenidate and Its Efficacy and Safety in Korean Children with ADHD: A Multisite Open Labeled Study
por: Song, Dong-Ho, et al.
Publicado: (2012)

Effect of Methylphenidate on Sleep Parameters in Children with ADHD
por: Lee, Sang Heon, et al.
Publicado: (2012)

Postural Instability in Children with ADHD Is Improved by Methylphenidate
por: Bucci, Maria P., et al.
Publicado: (2016)

The Effect of Methylphenidate on Neurological Soft Signs in ADHD
por: Hrtanek, Igor, et al.
Publicado: (2015)

Prediction of sleep side effects following methylphenidate treatment in ADHD youth
por: Yoo, Jae Hyun, et al.
Publicado: (2019)

Dopaminergic and Noradrenergic Contributions to Functionality in ADHD: The Role of Methylphenidate
por: Engert, Veronika, et al.
Publicado: (2008)

An observational study of once-daily modified-release methylphenidate in ADHD: effectiveness on symptoms and impairment, and safety
por: Döpfner, Manfred, et al.
Publicado: (2011)

ASD with ADHD vs. ASD and ADHD alone: a study of the QbTest performance and single-dose methylphenidate responding in children and adolescents
por: Stevanovic, Dejan, et al.
Publicado: (2022)

Efficacy and Safety of PRC-063, Extended-Release Multilayer Methylphenidate in Adults with ADHD Including 6-Month Open-Label Extension
por: Weiss, Margaret D., et al.
Publicado: (2020)

The influence of methylphenidate on the power spectrum of ADHD children – an MEG study
por: Wienbruch, Christian, et al.
Publicado: (2005)

Methylphenidate significantly improves declarative memory functioning of adults with ADHD
por: Verster, Joris C., et al.
Publicado: (2010)

Comorbidities in ADHD children treated with methylphenidate: a database study
por: Kraut, Angela A, et al.
Publicado: (2013)

Reduced pain perception in children and adolescents with ADHD is normalized by methylphenidate
por: Wolff, Nicole, et al.
Publicado: (2016)

Skin picking disorder comorbid with ADHD successfully treated with methylphenidate
por: Bernardes, Camila, et al.
Publicado: (2018)

Moderators and Other Predictors of Methylphenidate Response in Children and Adolescents with ADHD
por: D’Aiello, Barbara, et al.
Publicado: (2022)

Alpha/beta-gamma decoupling in methylphenidate medicated ADHD patients
por: Zammit, Nowell, et al.
Publicado: (2023)

Methylphenidate treatment of adult ADHD patients improves the degree of ADHD severity under routine conditions
por: Retz, Wolfgang, et al.
Publicado: (2020)

Methylphenidate Use for Emotional Dysregulation in Children and Adolescents with ADHD and ADHD and ASD: A Naturalistic Study
por: Ventura, Patrizia, et al.
Publicado: (2022)

Effect of Methylphenidate on State Anxiety in Children With ADHD-A Single Dose, Placebo Controlled, Crossover Study
por: Kritchman, Maya, et al.
Publicado: (2019)

Single-dose effects of methylphenidate and atomoxetine on functional connectivity during an n-back task in boys with ADHD
por: Kowalczyk, Olivia S., et al.
Publicado: (2023)

Long-Term (1 Year) Safety and Efficacy of Methylphenidate Modified-Release Long-Acting Formulation (MPH-LA) in Adults with Attention-Deficit Hyperactivity Disorder: A 26-Week, Flexible-Dose, Open-Label Extension to a 40-Week, Double-Blind, Randomised, Placebo-Controlled Core Study
por: Ginsberg, Y., et al.
Publicado: (2014)

The cardiovascular safety of methylphenidate
por: Jackson, John W
Publicado: (2016)

The Effects of Methylphenidate on Goal-directed Behavior in a Rat Model of ADHD
por: Natsheh, Joman Y., et al.
Publicado: (2015)

Methylphenidate-Induced Psychotic Symptoms in 65-Year-Old Female with ADHD
por: Ghadrdan, Elliyeh, et al.
Publicado: (2018)

Potential Negative Effects of Dextromethorphan as an Add-On Therapy to Methylphenidate in Children With ADHD
por: Chuang, Wei-Chen, et al.
Publicado: (2019)

Age-dependent, lasting effects of methylphenidate on the GABAergic system of ADHD patients
por: Solleveld, Michelle M., et al.
Publicado: (2017)

Cost-utility analysis of methylphenidate treatment for children and adolescents with ADHD in Brazil
por: Maia, Carlos R., et al.
Publicado: (2015)

Structural brain network topology underpinning ADHD and response to methylphenidate treatment
por: Griffiths, Kristi R., et al.
Publicado: (2021)

Regional brain volume predicts response to methylphenidate treatment in individuals with ADHD
por: Chang, Jung-Chi, et al.
Publicado: (2021)

Methylphenidate Hydrochloride Modified-Release in Adults with Attention Deficit Hyperactivity Disorder: A Randomized Double-Blind Placebo-Controlled Trial
por: Huss, Michael, et al.
Publicado: (2013)

How to Predict the Impact of Methylphenidate on Cardiovascular Risk in Children with Attention Deficit Disorder: Methylphenidate Improves Autonomic Dysfunction in Children with ADHD
por: Buchhorn, Reiner, et al.
Publicado: (2012)

Characteristics of ADHD Symptom Response/Remission in a Clinical Trial of Methylphenidate Extended Release
por: Weiss, Margaret, et al.
Publicado: (2019)

The Impact of Methylphenidate on QbTest Performance of Children with ADHD: A Retrospective Clinical Study
por: Knez, Rajna, et al.
Publicado: (2021)

Plasma concentrations of methylphenidate enantiomers in adults with ADHD and substance use disorder, with focus on high doses and relationship to carboxylesterase activity
por: Arvidsson, Michel, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_e7s1iil1ka3h31vpilisso5dke